TY  - ADVS
AU  - Verma,Sharad K.
TI  - Epigenetics as a paradigm for cancer treatment: chemically targeting the histone lysine methyltransferase EZH2 
T2  - The biomedical & life sciences collection,
PY  - 2015///
CY  - London
PB  - Henry Stewart Talks
KW  - Cancer
KW  - Genetic aspects
KW  - Treatment
KW  - Epigenesis
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Drug Discovery
KW  - methods
KW  - Epigenesis, Genetic
KW  - drug effects
KW  - Histone-Lysine N-Methyltransferase
KW  - antagonists & inhibitors
KW  - Histones
KW  - metabolism
KW  - Methyltransferases
KW  - Molecular Targeted Therapy
KW  - Neoplasms
KW  - diagnosis
KW  - drug therapy
KW  - genetics
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Cancer as an unmet medical need -- Epigenetics as a paradigm for treating cancer -- Histone lysine methyltransferase EZH2 as a target class example -- Development of EZH2 inhibitors; Access restricted to subscribers
UR  - https://hstalks.com/bs/3175/
ER  -